Kałwik M, Klepacz I, Mikołajczak P, Szwarc T, Groth D, Dubiel W, et al. Anti-CD20 MONOCLONAL ANTIBODIES IN THE TREATMENT OF MULTIPLE SCLEROSIS: MECHANISMS OF ACTION, CLINICAL EFFICACY, SAFETY, AND CONTEMPORARY THERAPEUTIC PERSPECTIVES. IJITSS [Internet]. 2026 Sep. 21 [cited 2026 Oct. 5];4(3(51). Available from: https://rspublisher.org/index.php/ijitss/article/view/6456